Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Stockholders' Deficit

v3.20.4
Condensed Statements of Stockholders' Deficit - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Mar. 31, 2019 $ 329 $ 3,449,516 $ (6,844,488) $ (3,394,643)
Balance, shares at Mar. 31, 2019 3,291,667      
Issuance of common stock in connection with notes payable $ 14 320,986 321,000
Issuance of common stock in connection with notes payable, shares 140,333      
Beneficial conversion feature in connection with notes payable 27,918 27,918
Stock-based compensation $ 200 3,713,756 3,713,956
Stock-based compensation, shares 2,000,000      
Issuance of common stock and warrants in connection with cancellation of consulting agreement $ 3 264,517 264,520
Issuance of common stock and warrants in connection with cancellation of consulting agreement, shares 33,333      
Issuance of common stock in connection with a consulting agreement $ 11 239,989 240,000
Issuance of common stock in connection with a consulting agreement, shares 106,667      
Net loss (7,301,685) (7,301,685)
Balance at Dec. 31, 2019 $ 557 8,016,682 (14,146,173) (6,128,934)
Balance, shares at Dec. 31, 2019 5,572,000      
Balance at Sep. 30, 2019 $ 546 6,664,582 (11,870,918) (5,205,790)
Balance, shares at Sep. 30, 2019 5,465,333      
Stock-based compensation 1,112,111 1,112,111
Stock-based compensation, shares      
Issuance of common stock in connection with a consulting agreement $ 11 239,989 240,000
Issuance of common stock in connection with a consulting agreement, shares 106,667      
Net loss (2,275,255) (2,275,255)
Balance at Dec. 31, 2019 $ 557 8,016,682 (14,146,173) (6,128,934)
Balance, shares at Dec. 31, 2019 5,572,000      
Balance at Mar. 31, 2020 $ 577 9,487,285 (16,448,359) (6,960,497)
Balance, shares at Mar. 31, 2020 5,774,778      
Issuance of common stock and warrants, net of fees $ 46 1,063,434 1,063,480
Issuance of common stock and warrants, net of fees, shares 463,333      
Issuance of common stock in satisfaction of accounts payable $ 6 121,829 121,835
Issuance of common stock in satisfaction of accounts payable, shares 54,149      
Issuance of common stock in connection with notes payable $ 37 1,133,613 1,133,650
Issuance of common stock in connection with notes payable, shares 366,667      
Issuance of common stock in connection with conversion of notes $ 157 4,493,466 4,493,623
Issuance of common stock in connection with conversion of notes, shares 1,568,802      
Issuance of common stock warrants 263,328  
Exercise of common stock warrants $ 10 (10)
Exercise of common stock warrants, shares 97,222      
Beneficial conversion feature in connection with notes payable 618,657 618,657
Issuance of common stock to consultants $ 11 302,098 302,109
Issuance of common stock to consultants, shares 108,099      
Stock-based compensation $ 133 10,662,861 10,662,994
Stock-based compensation, shares 1,333,333      
Canceled restricted stock awards $ (200) 200
Canceled restricted stock awards, shares (2,000,000)      
Common stock repurchased and subsequently canceled $ (17) (449,983) (450,000)
Common stock repurchased and subsequently canceled, shares (166,667)      
Reclassification of warrant liabilities   2,061,288   2,061,288
Net loss (20,081,908) (20,081,908)
Balance at Dec. 31, 2020 $ 760 29,758,066 (36,530,267) (6,771,441)
Balance, shares at Dec. 31, 2020 7,599,716      
Balance at Sep. 30, 2020 $ 955 26,084,744 (32,676,871) (6,591,172)
Balance, shares at Sep. 30, 2020 9,546,621      
Issuance of common stock in connection with notes payable $ 5 203,495 203,500
Issuance of common stock in connection with notes payable, shares 48,333      
Issuance of common stock to consultants 20,000 20,000
Issuance of common stock to consultants, shares 4,762      
Stock-based compensation 1,613,339 1,613,339
Stock-based compensation, shares      
Canceled restricted stock awards $ (200) 200
Canceled restricted stock awards, shares (2,000,000)      
Common stock repurchased and subsequently canceled (225,000) (225,000)
Common stock repurchased and subsequently canceled, shares      
Reclassification of warrant liabilities   2,061,288   2,061,288
Net loss (3,853,396) (3,853,396)
Balance at Dec. 31, 2020 $ 760 $ 29,758,066 $ (36,530,267) $ (6,771,441)
Balance, shares at Dec. 31, 2020 7,599,716